Monogram Technologies secured 510(k) clearance for its robotic knee replacement system, while Vicarious Surgical blamed ...
Vicarious Surgical (NYSE:RBOT) today announced fourth-quarter results that included an update on its surgical robot ...
Q4 2024 Earnings Call Transcript March 17, 2025 Vicarious Surgical Inc. beats earnings expectations. Reported EPS is $-2.43, ...
Piper Sandler lowered the firm’s price target on Vicarious Surgical (RBOT) to $8.50 from $10.50 and keeps a Neutral rating on the shares ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Vicarious Surgical (RBOT – Research Report), Alkermes (ALKS ...
Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today ...
Vicarious Surgical (NYSE:RBOT – Get Free Report) is expected to issue its quarterly earnings data after the market closes on ...
Vicarious Surgical Inc. (“Vicarious Surgical” or the “Company”) (NYSE: RBOT, RBOT WS), a next-generation robotics technology company seeking to improve lives by transforming robotic ...
Vicarious Surgical (NYSE:RBOT) announced today that it named Sarah Romano as its next chief financial officer (CFO).
Thank you for attending the Vicarious Surgical's 2024 fourth quarter and Full Year Earnings Call. My name is Cameron, and I will be your moderator for today (Operator Instructions) And I would now ...
Version 1.0 System Integration Complete; Progressing Towards First Clinical Use Achieved 2024 Cash Burn Guidance; Sets 2025 Cash Burn Guidance of $50 Million Vicarious Surgical Inc. (“Vicarious ...
Good afternoon. Thank you for attending the Vicarious Surgical's 2024 Fourth Quarter and Full Year Earnings Call. My name is Cameron and I will be your moderator for today. All lines have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results